My watch list  

Komen Brinker Award for Scientific Distinction

The Komen Brinker Award for Scientific Distinction was established by Susan G. Komen for the Cure in 1992 to recognize leading scientists for their significant work in advancing research concepts or clinical application in the fields of breast cancer research, screening or treatment.

The intent of the award is to recognize scholars for a specific contribution, a consistent pattern of contributions, or leadership in the field that has had a substantial impact on the fight against breast cancer. The awardees are nominated and selected by a panel of their peers. Recipients are also invited to present their work in a lecture at the annual San Antonio Breast Cancer Symposium (SABCS).

Past recipients of the Komen Brinker Award for Scientific Distinction include V. Craig Jordan, Ph.D., OBE a pioneer in the use of tamoxifen; Dr. Mary-Claire King, Ph.D., whose research isolated the BRCA1 and BRCA2 gene mutations associated with genetic forms of breast cancer; Larry Norton, M.D., whose dose-density approach to the administration of chemotherapy has revolutionized breast cancer treatment; Dr. Anita Roberts, who co-discovered the TGF-beta molecule; and Leland Hartwell, Ph.D., winner of the 2001 Nobel Prize for medicine or physiology who was recognized for his achievements in the understanding the cell cycle in the development of cancer.

Brinker Award recipients each receive a $20,000 honorarium and a special citation of this distinction.

See also

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Komen_Brinker_Award_for_Scientific_Distinction". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE